Company: SINT
Filing Date: 2025-03-19
Form Type: S-3
Source: 0001493152-25-010936
Chunk: 7

Company: Sintx Technologies, Inc.
Filing Date: 2025-03-19
Form: S-3
Chunk 7
---
                               |     | Our                                                                                                                                 
 common stock is listed on the Nasdaq Capital Market under the symbol “SINT.”                                                        |

The number of shares of common stock to be outstanding after this offering is based on 2,515,179 shares of common stock outstanding as of March 18, 2025 and excludes, in each case as of March 18, 2025:

| ● | 100,572                                                                                                                                
 shares of common stock issuable upon the exercise of outstanding options and restricted stock units granted under our equity incentive 
 plans at a weighted average exercise price of $17.17 per share;                                                                        |
| ● | 169,308                                                                                                                                
 shares of common stock issuable upon the exercise                                                                                      
 of outstanding warrants, excluding the Warrants;                                                                                       |
| ● | 7,385                                                                                                                                  
 shares of our common stock issuable upon the conversion of 19 shares of series B convertible preferred stock outstanding;              |
| ● | 2                                                                                                                                      
 shares of our common stock issuable upon the conversion of 50 shares of series C convertible preferred stock outstanding; and          |
| ● | 60                                                                                                                                     
 shares of common stock reserved for issuance upon conversion of 180 shares of the Series D Preferred Stock outstanding.                |

Unless otherwise indicated, the information in this prospectus, including the number of shares outstanding after this offering, does not reflect (i) any issuance, exercise, vesting, expiration, or forfeiture of any additional equity awards under our incentive plans that occurred after December 31, 2024 or (ii) the effect of the “full-ratchet” anti-dilution adjustment of the conversion price of our outstanding Series B Convertible Preferred Stock and the exercise price of our outstanding October 2022 warrants by this offering.

| 4 |

<div align='center'>SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS</div>

This prospectus and the documents we have filed with the SEC that are incorporated by reference contain “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Exchange Act, which involve risks and uncertainties. These statements relate to future events or to our future operating or financial performance and involve known and unknown risks, uncertainties and other factors that may cause our actual results, performance or achievements to be materially different from any future results, performances or achievements expressed or implied by the forward-looking statements. Forward-looking statements provide current expectations of future events based